P. Thomas
About
In The Last Decade
P. Thomas
433 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Pulmonary and Respiratory Medicine 7.9k
- Surgery 4.8k
- Oncology 2.2k
- Epidemiology 1.6k
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by P. Thomas
This map shows the geographic impact of P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Thomas more than expected).
Fields of papers citing papers by P. Thomas
This network shows the impact of papers produced by P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Thomas. The network helps show where P. Thomas may publish in the future.
Co-authorship network of co-authors of P. Thomas
This figure shows the co-authorship network connecting the top 25 collaborators of P. Thomas. A scholar is included among the top collaborators of P. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Thomas. P. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 31 | |
| 7 | CHILDHOOD MEASLES IS ASSOCIATED WITH LOWER RISK OF ADULT ATOPIC ASTHMA IN THE TAHS COHORT, BUT ONLY AMONG THOSE WHO HAD CHILDHOOD ECZEMA | 1 |
| 8 | 11 | |
| 9 | 7 | |
| 10 | Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 breakdown → | 413 |
| 11 | 19 | |
| 12 | 55 | |
| 13 | 22 | |
| 14 | 91 | |
| 15 | 73 | |
| 16 | 22 | |
| 17 | Development of lymphocytotoxic antibodies among lung transplant recipients: preliminary results. | 2 |
| 18 | Improvement in measurement of arsenic and selenium species by coupled high performance liquid chromatography-inductively coupled plasma mass spectrometry using time resolved analysis and chromatographic software | 11 |
| 19 | Consent for surgical treatment. | 4 |
| 20 | Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.